<p>DRI values for the drug combinations at 25%, 50%, 75% levels of inhibition of A549 cell proliferation.</p
<p>(A) Cell death was measured 48 h post treatment with non-fixed drug ratio combinations of IPI-504...
<p>Inhibition [%] of complexes 1 and 2 [dose level of 25.0 μM] against human tumor cells.</p
<p>The concentration of drugs that inhibits 50% of cell growth (IC<sub>50</sub>) compared to DMSO co...
<p>Dose Reduction indices (DRI) in synergysm experiments using drugs in constant ratio.</p
<p>(<b>A</b>) Summary table showing potency (Fa), CI and DRI values of erlotinib and miR-34a combine...
<p>Left hand panels: Growth inhibitory effects of combinations of trametinib with everolimus (TraEvl...
<p>Combination Index (CI) of conventional chemotherapeutic agents (at ED50) combined with IAP inhibi...
<p>(A) MTT assay of proliferation of cells treated with different concentrations of TQ and DG for 48...
<p>After 72h of continuous exposure to drugs (either trastuzumab or fulvestrant as single agents) hi...
<p>Panel (A, B and C) represents growth inhibition in BGC-823 and SGC-7901 cells with a combination ...
<p>The human lung cancer cell lines MDA-MB-231 and MDA-MB-468 breast cancer cells were obtained from...
<p>IC<sub>50</sub> values (µM) of thalidomide derivatives for inhibiting proliferation of multiple m...
<p>DRRCs for cisplatin (CDDP), suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA) admini...
<p>(A) Cells were treated with HSP70 inhibitor, (VER155008) for 72 h. The relative viability and ICs...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p>(A) Cell death was measured 48 h post treatment with non-fixed drug ratio combinations of IPI-504...
<p>Inhibition [%] of complexes 1 and 2 [dose level of 25.0 μM] against human tumor cells.</p
<p>The concentration of drugs that inhibits 50% of cell growth (IC<sub>50</sub>) compared to DMSO co...
<p>Dose Reduction indices (DRI) in synergysm experiments using drugs in constant ratio.</p
<p>(<b>A</b>) Summary table showing potency (Fa), CI and DRI values of erlotinib and miR-34a combine...
<p>Left hand panels: Growth inhibitory effects of combinations of trametinib with everolimus (TraEvl...
<p>Combination Index (CI) of conventional chemotherapeutic agents (at ED50) combined with IAP inhibi...
<p>(A) MTT assay of proliferation of cells treated with different concentrations of TQ and DG for 48...
<p>After 72h of continuous exposure to drugs (either trastuzumab or fulvestrant as single agents) hi...
<p>Panel (A, B and C) represents growth inhibition in BGC-823 and SGC-7901 cells with a combination ...
<p>The human lung cancer cell lines MDA-MB-231 and MDA-MB-468 breast cancer cells were obtained from...
<p>IC<sub>50</sub> values (µM) of thalidomide derivatives for inhibiting proliferation of multiple m...
<p>DRRCs for cisplatin (CDDP), suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA) admini...
<p>(A) Cells were treated with HSP70 inhibitor, (VER155008) for 72 h. The relative viability and ICs...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p>(A) Cell death was measured 48 h post treatment with non-fixed drug ratio combinations of IPI-504...
<p>Inhibition [%] of complexes 1 and 2 [dose level of 25.0 μM] against human tumor cells.</p
<p>The concentration of drugs that inhibits 50% of cell growth (IC<sub>50</sub>) compared to DMSO co...
DOI
Add to ORKG